sch 42495 has been researched along with moxonidine in 1 studies
*moxonidine: structure given in first source [MeSH]
*moxonidine: structure given in first source [MeSH]
| Studies (sch 42495) | Trials (sch 42495) | Recent Studies (post-2010) (sch 42495) | Studies (moxonidine) | Trials (moxonidine) | Recent Studies (post-2010) (moxonidine) |
|---|---|---|---|---|---|
| 18 | 5 | 0 | 505 | 86 | 89 |
| Protein | Taxonomy | sch 42495 (IC50) | moxonidine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.7021 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.7021 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gregoire, JR; Sheps, SG | 1 |
1 review(s) available for sch 42495 and moxonidine
| Article | Year |
|---|---|
Newer antihypertensive drugs.
Topics: Antihypertensive Agents; Dibenzothiepins; Humans; Imidazoles; Methionine; Oxazoles; Piperazines; Protease Inhibitors; Rilmenidine | 1995 |